Rhythm Biosciences Limited (FRA:0RY)
0.0810
-0.0290 (-26.36%)
At close: Jan 30, 2026
Rhythm Biosciences Revenue
In the fiscal year ending June 30, 2025, Rhythm Biosciences had annual revenue of 3.19M AUD with 88.85% growth. Rhythm Biosciences had revenue of 25.63K in the half year ending June 30, 2025, a decrease of -93.16%.
Revenue
3.19M AUD
Revenue Growth
+88.85%
P/S Ratio
15.67
Revenue / Employee
n/a
Employees
n/a
Market Cap
27.92M EUR
Revenue Chart
* This company reports financials in AUD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.19M | 1.50M | 88.85% |
| Jun 30, 2024 | 1.69M | -1.41M | -45.41% |
| Jun 30, 2023 | 3.10M | 668.44K | 27.54% |
| Jun 30, 2022 | 2.43M | 1.32M | 118.98% |
| Jun 30, 2021 | 1.11M | 1.01M | 1,008.51% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 1.22B |
| edding AG | 149.67M |
| ACCENTRO Real Estate AG | 77.32M |
| Hyrican Informationssysteme Aktiengesellschaft | 24.26M |
| OTRS AG | 12.08M |
| Weng Fine Art AG | 2.48M |
| Rubean AG | 1.78M |
| Petro Matad | 1.73M |